Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Depreciation and Depletion (2024 - 2025)

Historic Depreciation and Depletion for United Therapeutics (UTHR) over the last 2 years, with Q3 2025 value amounting to $21.5 million.

  • United Therapeutics' Depreciation and Depletion rose 1436.17% to $21.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.4 million, marking a year-over-year change of. This contributed to the annual value of $71.6 million for FY2024, which is 3534.97% up from last year.
  • Latest data reveals that United Therapeutics reported Depreciation and Depletion of $21.5 million as of Q3 2025, which was up 1436.17% from $20.9 million recorded in Q2 2025.
  • In the past 5 years, United Therapeutics' Depreciation and Depletion ranged from a high of $21.5 million in Q3 2025 and a low of $14.8 million during Q1 2024